Variant Bio
Variant Bio is a biotechnology company developing life-saving therapies by studying the genes of people with exceptional health-related traits. Working with partner communities around the world under an ethical, benefit-sharing approach, the company pairs large-scale genomic discovery with data science to turn genetic diversity into novel drug targets across metabolic, cardiovascular and other disease areas. Surfaced as a portfolio company of General Catalyst, Lux Capital and SoftBank Vision Fund and profiled in the API Evangelist network; Variant Bio publishes no public developer/API surface at this time.
Variant Bio is profiled on the APIs.io network. Tagged areas include Company, Genomics, Therapeutics, Drug Discovery, and Biotechnology.
Variant Bio’s developer surface includes engineering blog and 3 more developer resources.
Kin Score
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Access & Security 1
Authentication, authorization, and security posture
Commercial 1
Pricing, plans, and the legal terms of use
Company 2
The organization behind the API